NYLI Epoch International Choice Fund I (ICEUX)
39.69
+0.54
(+1.38%)
USD |
Apr 11 2025
Key Stats
Customize
| Net Expense Ratio | Total Assets Under Management | Weighted Average Dividend Yield | Turnover Ratio (Generic) |
|---|---|---|---|
| 0.95% | 237.62M | 2.64% | 60.00% |
| 1 Year Fund Level Flows | 1 Year Total Returns (Daily) | Annualized Total Returns Since Inception (Daily) | Max Drawdown (Since Inception) |
| 12.44M | 0.54% | Upgrade | Upgrade |
Basic Info
| Investment Strategy | |
| The Fund seeks total return. Under normal circumstances the Fund will invest at least 80% of its assets in foreign equity securities which includes common stock depository receipts and securities convertible into common stock such as warrants rights convertible bonds debentures and convertible preferred stocks. |
| General | |
| Security Type | Mutual Fund |
| Broad Asset Class | International Equity |
| Broad Category | Equity |
| Global Peer Group | Equity Global ex US |
| Peer Group | International Large-Cap Growth |
| Global Macro | Equity Global |
| US Macro | Developed International Markets Funds |
| YCharts Categorization | -- |
| YCharts Benchmark | -- |
| Prospectus Objective | International Funds |
| Fund Owner Firm Name | New York Life Investments |
| Broad Asset Class Benchmark Index | |
| ^MSACXUSNTR | 100.0% |
Net Fund Flows Versus Peer Group
1 Month
% Rank:
73
-3.363B
Peer Group Low
673.38M
Peer Group High
1 Year
% Rank:
23
12.44M
-15.30B
Peer Group Low
6.825B
Peer Group High
3 Months
% Rank:
56
-4.670B
Peer Group Low
5.128B
Peer Group High
3 Years
% Rank:
45
-49.81B
Peer Group Low
17.40B
Peer Group High
6 Months
% Rank:
20
-9.467B
Peer Group Low
5.109B
Peer Group High
5 Years
% Rank:
66
-75.14B
Peer Group Low
31.45B
Peer Group High
YTD
% Rank:
57
-4.670B
Peer Group Low
5.128B
Peer Group High
10 Years
% Rank:
89
-78.09B
Peer Group Low
36.66B
Peer Group High
Date Unavailable
Risk
Performance Versus Peer Group
Annual Total Returns Versus Peers
As of April 12, 2025.
Asset Allocation
As of January 31, 2025.
| Type | % Net |
|---|---|
| Cash | -1.01% |
| Stock | 98.68% |
| Bond | 0.00% |
| Convertible | 0.00% |
| Preferred | 0.00% |
| Other | 2.33% |
Top 10 Holdings
| Name | % Weight | Price | % Change |
|---|---|---|---|
| AstraZeneca PLC | 4.80% | 66.29 | 2.19% |
| Keyence Corp | 3.96% | 384.00 | -0.18% |
| Sony Group Corp | 3.83% | 22.62 | -1.64% |
| AXA SA | 3.68% | 42.26 | 2.97% |
| Lloyds Banking Group PLC | 3.59% | 0.8563 | -2.69% |
| NN Group NV | 3.54% | 55.13 | 4.04% |
| Novo Nordisk AS | 3.48% | 64.44 | 5.47% |
| Linde PLC | 3.35% | 441.83 | 2.30% |
| Unilever PLC | 3.32% | 59.87 | -2.24% |
| Deutsche Telekom AG | 3.30% | 35.62 | 2.83% |
Fees & Availability
| Fees | |
| Actual 12B-1 Fee | -- |
| Actual Management Fee | 0.78% |
| Administration Fee | -- |
| Maximum Front Load | -- |
| Maximum Deferred Load | -- |
| Maximum Redemption Fee | 0.00% |
| General Availability | |
| Available for Insurance Product | -- |
| Available for RRSP | -- |
| Purchase Details | |
| Open to New Investors |
|
| Minimum Initial Investment | 1.00M None |
| Minimum Subsequent Investment | 0.00 None |
Basic Info
| Investment Strategy | |
| The Fund seeks total return. Under normal circumstances the Fund will invest at least 80% of its assets in foreign equity securities which includes common stock depository receipts and securities convertible into common stock such as warrants rights convertible bonds debentures and convertible preferred stocks. |
| General | |
| Security Type | Mutual Fund |
| Broad Asset Class | International Equity |
| Broad Category | Equity |
| Global Peer Group | Equity Global ex US |
| Peer Group | International Large-Cap Growth |
| Global Macro | Equity Global |
| US Macro | Developed International Markets Funds |
| YCharts Categorization | -- |
| YCharts Benchmark | -- |
| Prospectus Objective | International Funds |
| Fund Owner Firm Name | New York Life Investments |
| Broad Asset Class Benchmark Index | |
| ^MSACXUSNTR | 100.0% |
Fundamentals
| General | |
| Distribution Yield | -- |
| Dividend Yield TTM (4-11-25) | 1.61% |
| 30-Day SEC Yield (6-30-21) | 1.00% |
| 7-Day SEC Yield | -- |
| Stock | |
| Weighted Average PE Ratio | 22.10 |
| Weighted Average Price to Sales Ratio | 4.046 |
| Weighted Average Price to Book Ratio | 4.907 |
| Weighted Median ROE | 20.08% |
| Weighted Median ROA | 7.63% |
| ROI (TTM) | 13.52% |
| Return on Investment (TTM) | 13.52% |
| Earning Yield | 0.0627 |
| LT Debt / Shareholders Equity | 0.8352 |
As of January 31, 2025
Growth Metrics
| EPS Growth (1Y) | 20.46% |
| EPS Growth (3Y) | 20.00% |
| EPS Growth (5Y) | 12.37% |
| Sales Growth (1Y) | 10.04% |
| Sales Growth (3Y) | 12.60% |
| Sales Growth (5Y) | 8.69% |
| Sales per Share Growth (1Y) | 11.93% |
| Sales per Share Growth (3Y) | 12.87% |
| Operating Cash Flow - Growth Ratge (3Y) | 9.89% |
As of January 31, 2025
Fund Details
Top Portfolio Holders
| Name | % Weight |
|---|---|
| Portfolio A | 5.00% |
| Portfolio B | 3.50% |
| Portfolio C | 2.25% |
Excel Add-In Codes
| Name: =YCI("M:ICEUX", "name") |
| Broad Asset Class: =YCI("M:ICEUX", "broad_asset_class") |
| Broad Category: =YCI("M:ICEUX", "broad_category_group") |
| Prospectus Objective: =YCI("M:ICEUX", "prospectus_objective") |
| To find the codes for any of our securities and financial metrics, see our Complete Excel Reference. |